Antagonists of prostaglandin D2 receptors

Details for Australian Patent Application No. 2009266793 (hide)

Owner Amira Pharmaceuticals, Inc.

Inventors Hutchinson, John Howard; Stearns, Brian Andrew; Seiders, Thomas Jon; Wang, Bowei; Arruda, Jeannie M.

Agent Spruson & Ferguson

Pub. Number AU-A-2009266793

PCT Pub. Number WO2010/003120

Priority 61/078,311 03.07.08 US

Filing date 2 July 2009

Wipo publication date 7 January 2010

International Classifications

C07C 323/57 (2006.01) Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

A61K 31/10 (2006.01)

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

C07C 321/20 (2006.01) Thiols, sulfides, hydropolysulfides or polysulfides

Event Publications

10 February 2011 PCT application entered the National Phase

  PCT publication WO2010/003120 Priority application(s): WO2010/003120

7 June 2012 Assignment before Grant

  Amira Pharmaceuticals, Inc. The application has been assigned to Panmira Pharmaceuticals, LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009266797-Solar power generation assembly and method for providing same

2009266761-Artificial kidney precursor and process for production thereof